Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
Epithelial cell adhesion molecule (EpCAM) is a type I transmembrane glycoprotein overexpressed in human epithelioma but with relatively low expression in normal epithelial tissues. To exploit this differential expression pattern for targeted cancer therapy, an EpCAM-targeted immunotoxin was develope...
Saved in:
Main Authors: | Minghua Lv (Author), Feng Qiu (Author), Tingting Li (Author), Yuanjie Sun (Author), Chunmei Zhang (Author), Ping Zhu (Author), Xiaokun Qi (Author), Jun Wan (Author), Kun Yang (Author), Kui Zhang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
by: Seyed-Ali Hosseinian, et al.
Published: (2018) -
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients
by: Mark Kowalski, et al.
Published: (2010) -
Tufting enteropathy with EpCAM mutation: case report
by: Karla Lais Pêgas, et al.
Published: (2014) -
Statistical optimization of culture conditions for expression of recombinant humanized anti-EpCAM single-chain antibody using response surface methodology
by: Aidin Behravan, et al.
Published: (2021) -
Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
by: Weizhen Li, et al.
Published: (2021)